ACHE and Alzheimer disease: This mechanism not only directly targets the cholinergic system dysfunction that is characteristic of AD but, with further research, it has also been found that AChE inhibitors may exert neuroprotective effects through a variety of pathways, providing an important intervention target for AD treatment.